Upregulation of these inflammatory mediators has been linked to the pathogenesis of autoimmune disorders, and plays a potential role in tumor progression and metastasis (see Figure 2) [33,34,35] as well as the pathogenesis of autoimmune neurological diseases (CCL20) [34]. Here, CCL20 is linked to autoimmune disease.